China Business - Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia

Started by MikeLigalig.com, February 27, 2013, 09:56:09 AM

Previous topic - Next topic

MikeLigalig.com

Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia

By a News Reporter-Staff News Editor at China Business Newsweekly -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced that they have formed an exclusive alliance to develop and commercialize RNAi therapeutics targeting transthyretin ... (Publication: China Business Newsweekly)

Source: Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia
For God so loved the world, that he gave his only Son (Jesus Christ), that whoever believes in him should not perish but have eternal life. For God did not send his Son into the world to condemn the world, but in order that the world might be saved through him. Whoever believes in him is not condemned, but whoever does not believe is condemned already, because he has not believed in the name of the only Son of God. - John 3:16-18

● ● ● ●
MOST AFFORDABLE health insurance HMO in the Philippines. Learn more at https://kwik.insure/at/mligalig